First COPD Patient Treated in Holaira's Sham Controlled Trial of Targeted Lung Denervation
MINNEAPOLIS, MN -- (Marketwired) -- 08/03/16 -- Holaira, a developer of medical devices to treat obstructive lung diseases, announced the initiation of treatments in the AIRFLOW-2 Clinical Trial for patients with moderate to severe chronic obstructive …